RE:RE:RE:Thanks but no thanksThe no's have it hands down, however, all the posts here count for nothing. Here are the options:
1. stand by, vote and hope shareholders vote this down (if passed it is done like dinner and over. It is very unlikely the courts will not overturn a shareholder vote. A vote in favour would also likely mitigate any possible legal action against managment and directors.
2. Legal action must be started. How, I am not sure, but against management and the board, what comes to mind is: breach of feduciary duty and responsibility to shareholders, on the basis of deal terms. Regarding the vote, file an injunction to stop the vote pending an outcome of a lawsuit against management and the board. Any lawyers here could add to this and flush it out. What I am 100% sure of is that if shareholders take no legal action, the likelyhood of the DML deal passing is very high.
3. Complaining to the stock exchange is a waste of time as the regulations are very loose and rarely enforced IF there is an explicity complaint, and when they are, there is usually only a trivial fine involvied and a suspension of trading privileges.
EquityInvestor1 wrote: No worries - I will continue to point out how your actions are clearly not in the best interests of FCU shareholders and how how very long posts serve only to distract FCU shareholders from the only issue that should be on their mind at this point:
Does the merger truly reflect an equal contibution of assets by the two companies (as advertised after integrating the share ratio fudge factor) and on this basis, should the merger be supported or rebuked vigourously.
I think we all believe that FCU is contributing considerably more value then DML and thus virtually everything in your posts is not relevant (at this time) as the merger should be voted down on the basis of a properly performed fairness assessment alone which FCU management claims to have obtained verbally (really) yet refuses to provide relevent documentation to dissident sharholders concerning this mater.